H1-antihistamines for primary mast cell activation syndromes: a systematic review.

Nurmatov, U B; Rhatigan, E; Simons, F E R; Sheikh, A

Nurmatov, U B; Rhatigan, E; Simons, F E R; Sheikh, A.

Affiliation

Nurmatov UB; Allergy and Respiratory Research Group, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK.
Rhatigan E; Victoria Hospital Kirkcaldy, NHS Fife, Kirkcaldy, Fife, UK.
Simons FE; Departments of Pediatrics and Child Health, and Immunology, University of Manitoba, Winnipeg, MB, Canada.
Sheikh A; Allergy and Respiratory Research Group, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK.

Allergy ; 70(9): 1052-61, 2015 Sep.

Article in En | MEDLINE | ID: mdl-26095756

Subject(s)

Histamine H1 Antagonists/therapeutic use; Mastocytosis/drug therapy; Disease Management; Histamine H1 Antagonists/pharmacology; Humans; Mast Cells/drug effects; Mast Cells/immunology; Mast Cells/metabolism; Mastocytosis/diagnosis; Randomized Controlled Trials as Topic; Syndrome; Treatment Outcome

Key words

H1-antihistamines; mastocytosis; primary mast cell activation syndrome; systematic review

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mastocytosis / Histamine H1 Antagonists Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies / Systematic_reviews Aspects: Patient_preference Limits: Humans Language: En Journal: Allergy Year: 2015 Document type: Article Affiliation country: United kingdom Country of publication: Denmark

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google